RNA Stock-Based Compensation

Atrium Therapeutics Inc · Stock-Based Compensation

RNA stock-based compensation history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.